openPR Logo
Press release

Antibodies Top Companies Regional and Data Analysis to 2031

07-17-2025 10:06 AM CET | Health & Medicine

Press release from: The Insight Partners

Immunoglobulins (Ig) are another name for antibodies (Ab). These are big, Y-shaped proteins produced predominantly by plasma cells in the bloodstream in response to pathogens like viruses and bacteria. Antibodies have the ability to recognise specific molecules associated with hazardous substances.

Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00005787?utm_source=OpenPR&utm_medium=10413

Key Company Profiles

Merck KGaA
Cell Signalling Technology, Inc.
BD
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Beckman Coulter, Inc.
GenScript
QIAGEN

Segments Covered

By Type
Monoclonal Antibodies
Polyclonal Antibodies
ADCs

By Technology
Western Blotting
Flow Cytometry
ELISA
Immunohistochemistry
Immunofluorescence
Immunoprecipitation

By Application
Proteomics
Drug Development
Genomics

By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
CRO's

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibodies Top Companies Regional and Data Analysis to 2031 here

News-ID: 4107753 • Views:

More Releases from The Insight Partners

Rising Hygiene Standards Propel Medical Scrub Market Growth at a 6.3% CAGR
Rising Hygiene Standards Propel Medical Scrub Market Growth at a 6.3% CAGR
New York, US - October 24, 2025 - The Medical Scrub Market is undergoing a transformative phase, shaped by the increasing focus on healthcare hygiene, professional aesthetics, and sustainable apparel solutions. With hospitals, clinics, and healthcare institutions prioritizing infection control and comfort, medical scrubs have evolved from simple uniforms into advanced garments that blend technology, protection, and style. According to recent insights, the market is projected to grow at a CAGR
Beauty Devices Market: Demand Analysis, Key Players, Trends, Sales, Supply, Deployment Model Revenue Data & Forecast to 2031
Beauty Devices Market: Demand Analysis, Key Players, Trends, Sales, Supply, Depl …
Global Beauty Devices Market Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00008260?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: NuFACE The Procter & Gamble Co. Koninklijke Philips NV Panasonic Holdings Corp. Tria Beauty Foreo Ya-Man LTD ZIIP Silk?n, MTG Co., Ltd The report covers key developments in the Beauty Devices Market as organic and inorganic growth strategies. Various companies are focusing
Practice Management Systems Market by Medical Composition, Type, End-Use Industry and Region Analysed with Trends and Forecasts to 2031
Practice Management Systems Market by Medical Composition, Type, End-Use Industr …
Global Practice Management Systems Market Report is a professional and in-depth survey on the current state of the Cervical Pillows Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Practice Management Systems Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPHC00002219?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: GE HealthCare Technologies Inc Athenahealth
Wireless Sensors Precision Agriculture Environmental Market to Expand at 8.3% CAGR by 2031
Wireless Sensors Precision Agriculture Environmental Market to Expand at 8.3% CA …
The Insight Partners is proud to announce its newest market report, "Wireless Sensors Precision Agriculture Environmental Market: An In-depth Analysis of the Wireless Sensors Precision Agriculture Environmental Market." The report provides a holistic view of the Wireless Sensors Precision Agriculture Environmental Market and describes the current scenario as well as the growth estimates of the market during the forecast period. Check valuable insights in the Wireless Sensors Precision Agriculture Environmental Market

All 5 Releases


More Releases for Antibodies

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights: • Global & Regional Market Analysis • Global Multispecific Antibodies Market Opportunity: > USD 40 Billion • Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion • Number Of Approved Multispecific Antibodies: 14 • Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight • Approved Antibodies Dosage & Pricing Insight • Number Of Multispecific Antibodies: In Clinical Trials: > 900 • Comprehensive Insight On All Antibodies In Clinical Trials By
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Tetravalent antibodies are designed to engage